Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MIF | P14174 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL91215 | 0.94 | TDP1 (0.46) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL9613490 | 0.94 | TDP1 (0.46) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL11982130 | 0.94 | TDP1 (0.46) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL4015650 | 0.93 | SMN1; SMN2 (0.45) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL4015654 | 0.93 | SMN1; SMN2 (0.45) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL25161948 | 0.85 | SMN1; SMN2 (0.47) | TDP1ALDH1A1MAPTHTTKMT2A | |
| SCHEMBL4017926 | 0.85 | SMN1; SMN2 (0.47) | TDP1ALDH1A1MAPTHTTKMT2A | |
| SCHEMBL4017923 | 0.85 | SMN1; SMN2 (0.47) | TDP1ALDH1A1MAPTHTTKMT2A | |
| SCHEMBL5046323 | 0.84 | TP53 (0.47) | ALDH1A1MAPTSMN1; SMN2TP53CHRNB2 | |
| SCHEMBL637275 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118719136-A | Catalyst for epoxidation of bicyclo-diene compound as well as preparation method and application thereof | 清华大学 | 2024-10-01 | — | — | CN | disclosed |
| US-8124816-B2 | Hydrogenation of esters with Ru/tetradentate ligands complexes | FIRMENICH SA (CH) | 2012-02-28 | — | — | US | disclosed |
| US-7989665-B2 | Hydrogenation of esters with Ru/tetradentate ligands complexes | FIRMENICH SA (CH) | 2011-08-02 | — | — | US | disclosed |
| US-20100125144-A1 | HYDROGENATION OF ESTERS WITH RU/TETRADENTATE LIGANDS COMPLEXES | SAUDAN LIONEL | 2010-05-20 | — | — | US | disclosed |
| US-20080071098-A1 | Forming alcohols or diols; using coordination catalyst | FIRMENICH SA (CH) | 2008-03-20 | — | — | US | disclosed |
| EP-0847417-B1 | COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATES AND EPOXY COMPOUNDS | CYTEC TECH CORP (US) | 2004-11-24 | — | — | EP | disclosed |
| EP-1242529-A1 | FORMALDEHYDE FREE 1,3,5-TRIAZINE CARBAMATE CROSSLINKERS AND CURABLE COMPOSITIONS CONTAINING SAME | CYTEC TECHNOLOGY CORP. (US) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001040368-A1 | FORMALDEHYDE FREE 1,3,5-TRIAZINE CARBAMATE CROSSLINKERS AND CURABLE COMPOSITIONS CONTAINING SAME | CYTEC TECHNOLOGY CORP. (US) | 2001-06-07 | — | — | WO | disclosed |
| US-6130297-A | CURABLE COATING MIXTURE TO FORM FILMS WITH HARDNESS,IMPACT AND SOLVENT RESISTANCE, SMOOTH LOW GLOSS FINISH | CYTEC TECHNOLOGY CORP. (US) | 2000-10-10 | — | — | US | disclosed |
| EP-0935635-A1 | LIQUID CROSS-LINKER COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATE/AMINOPLAST RESIN MIXTURES | Cytec Technology Corp. (US) | 1999-08-18 | — | — | EP | disclosed |
| EP-0931104-A1 | CROSSLINKER COMPOSITIONS AND LOW GLOSS EPOXY COATINGS THEREFROM | Cytec Technology Corp. (US) | 1999-07-28 | — | — | EP | disclosed |
| US-5925285-A | CARBOXYLIC CROSSLINKING AGENTS FOR COATINGS WITH EPOXY GROUPS | CYTEC TECHNOLOGY CORP. (US) | 1999-07-20 | — | — | US | disclosed |
| US-5852133-A | Curable compositions containing 1,3,5-triazine carbamates and epoxy compounds | CYTEC TECHNOLOGY CORP. (US) | 1998-12-22 | — | — | US | disclosed |
| EP-0847417-A1 | COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATES AND EPOXY COMPOUNDS | Cytec Technology Corp. (US) | 1998-06-17 | — | — | EP | disclosed |
| WO-1998018856-A1 | LIQUID CROSS-LINKER COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATE/AMINOPLAST RESIN MIXTURES | CYTEC TECHNOLOGY CORP. (US) | 1998-05-07 | — | — | WO | disclosed |
| WO-1998015587-A1 | CROSSLINKER COMPOSITIONS AND LOW GLOSS EPOXY COATINGS THEREFROM | CYTEC TECHNOLOGY CORP. (US) | 1998-04-16 | — | — | WO | disclosed |
| WO-1997008235-A1 | COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATES AND EPOXY COMPOUNDS | CYTEC TECHNOLOGY CORP. (US) | 1997-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080071098-A1 | Forming alcohols or diols; using coordination catalyst | ADH1C, ADH1A, ADH5 | TDP1 3539/4885MIF 1664/4885ALDH1A1 366/4885 |
| US-20100125144-A1 | HYDROGENATION OF ESTERS WITH RU/TETRADENTATE LIGANDS COMPLEXES | ADH5, ADH1C, ADH1A | TDP1 4138/4885MIF 501/4885ALDH1A1 1561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.